Literature DB >> 32417596

Novel findings of HLA association with anti-LGI1 encephalitis: HLA-DRB1*03:01 and HLA-DQB1*02:01.

Fayun Hu1, Xu Liu1, Le Zhang1, Chu Chen1, Xue Gong1, Jingfang Lin1, Dongmei An1, Dong Zhou2, Zhen Hong3.   

Abstract

This study was to investigate whether autoimmune encephalitis is associated with the human leukocyte antigen (HLA) genotypes in Chinese Han population. We compared and analyzed the HLA genotypes of 101 patients with autoimmune encephalitis (77 anti-NMDAR, 11 anti-LGI1 and 13 anti-GABABR antibody, respectively) to the 200 healthy control groups. Our results showed that the DRB1*03:01 or DQB1*02:01 allele and the extended DRB1*03:01 ~ DQB1*02:01 haplotype represented the strong susceptibility locus for anti-LGI1 encephalitis (OR = 18.84, 95% CI = 5.01-70.89, Pc = 0.004; OR = 18.84, 95% CI = 5.01-70.89, Pc = 0.004; OR = 18.84, 95% CI = 5.01-70.89, Pc = 0.001). Additionally, the DRB1*08:03 ~ DQB1*06:01 or B*08:01 ~ C*07:02 haplotype was likely to be associated with anti-LGI1 encephalitis (OR = 10.23, 95% CI = 2.87-36.42, Pc = 0.039; OR = 74.62, 95% CI = 6.97-799.06, Pc = 0.043). No statistically significant differences were found for HLA association between patients with anti-NMDAR or anti-GABABR encephalitis and healthy controls. These results indicated that HLA subtypes were only associated with anti-LGI1 encephalitis.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Anti-GABA(B) antibody; Anti-LGI1 antibody; Anti-NMDAR antibody; Autoimmune encephalitis; HLA gene

Year:  2020        PMID: 32417596     DOI: 10.1016/j.jneuroim.2020.577243

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  6 in total

1.  Autoimmune encephalitis associated with anti-LGI1 antibody and Sjögren's syndrome: a case report.

Authors:  Yinyin Xie; Hongmei Meng; Buajieerguli Maimaiti; Miaomiao Yu; Yang Zhao
Journal:  Neurol Sci       Date:  2021-06-10       Impact factor: 3.307

Review 2.  Autoantibody Encephalitis: Presentation, Diagnosis, and Management.

Authors:  Eric Lancaster
Journal:  J Clin Neurol       Date:  2022-07       Impact factor: 2.566

3.  Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis.

Authors:  Sergio Muñiz-Castrillo; Julie Haesebaert; Laure Thomas; Alberto Vogrig; Anne-Laurie Pinto; Géraldine Picard; Charlotte Blanc; Le-Duy Do; Bastien Joubert; Giulia Berzero; Dimitri Psimaras; Agusti Alentorn; Véronique Rogemond; Valérie Dubois; Aditya Ambati; Ryad Tamouza; Emmanuel Mignot; Jérôme Honnorat
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-03-05

4.  The First Case of Familiar Anti-leucine-rich Glioma-Inactivated1 Autoimmune Encephalitis: A Case Report and Literature Review.

Authors:  Chuhan Ding; Qibing Sun; Ran Li; Hanli Li; Yu Wang
Journal:  Front Neurol       Date:  2022-04-14       Impact factor: 4.003

Review 5.  Short- and Long-Lived Autoantibody-Secreting Cells in Autoimmune Neurological Disorders.

Authors:  C Zografou; A G Vakrakou; P Stathopoulos
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

6.  Human Leukocyte Antigen Association Study Reveals DRB1*04:02 Effects Additional to DRB1*07:01 in Anti-LGI1 Encephalitis.

Authors:  Vicente Peris Sempere; Sergio Muñiz-Castrillo; Aditya Ambati; Sophie Binks; Anne-Laurie Pinto; Veronique Rogemond; Sean J Pittock; Divyanshu Dubey; Michael D Geschwind; Jeffrey Marc Gelfand; Sonam Dilwali; Soon-Tae Lee; Julian Knight; Katherine S Elliott; Sarosh Irani; Jérôme Honnorat; Emmanuel Mignot
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2022-02-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.